CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Zealand's royalty deal; Khartis raises money for TED drug

TED drugPositive
AI Analysis

Summary

Khartis Therapeutics raised $50M in Series B funding from Forge Life Science Partners, Longwood Fund, and Lilly Asia Ventures to advance its TED drug programs. Zealand also announced a royalty deal in related news.

Importance:5/10
Sentiment:
0.50
Series B fundingbiotech financingSan DiegoTED therapeutic area
Related Companies

Read the original article

Published by Endpoints News on August 13, 2026 2:19 PM

Read Original